Bone Marrow TransplantationBone MarrowHematologic NeoplasmsTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousLeukemiaWhole-Body IrradiationHematopoietic Stem Cell TransplantationTransplantation ConditioningBone and BonesAnemia, AplasticTransplantation ChimeraTissue DonorsLiver TransplantationGraft SurvivalBusulfanHistocompatibility TestingHistocompatibilityBone Marrow PurgingHematopoietic Stem CellsCyclophosphamideLeukemia, Myeloid, AcuteTreatment OutcomeRecurrenceTransplantation, IsogeneicLymphoma, Non-HodgkinCombined Modality TherapyBone Marrow DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoiesisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveKidney TransplantationLeukemia, MyeloidLymphomaMyelodysplastic SyndromesImmunosuppressive AgentsMice, Inbred C57BLTime FactorsRetrospective StudiesRemission InductionRadiation ChimeraAcute DiseaseBone Marrow ExaminationGraft RejectionHepatic Veno-Occlusive DiseaseStem Cell TransplantationSurvival AnalysisTransplantation ImmunologyLymphocyte DepletionMultiple MyelomaLeukocyte TransfusionImmunosuppressionBone RemodelingHematologic DiseasesBone Marrow NeoplasmsHLA AntigensT-LymphocytesGraft vs Host ReactionLymphocyte TransfusionSurvival RateChimeraHeart TransplantationAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationGraft vs Tumor EffectFollow-Up StudiesActuarial AnalysisNeoplasmsCyclosporineSevere Combined ImmunodeficiencyColony-Forming Units AssayGraft vs Leukemia EffectHodgkin DiseaseLung TransplantationPrognosisNuclear FamilyOpportunistic InfectionsImmunocompromised HostDisease-Free SurvivalBone DensityCell DifferentiationLeukocyte CountFlow CytometryGranulocyte Colony-Stimulating FactorCytarabineAntineoplastic AgentsOrgan TransplantationCarmustineFatal OutcomeMelphalanCytomegalovirus InfectionsPancytopeniaPeripheral Blood Stem Cell TransplantationMice, Inbred BALB CEtoposideNeutropeniaAntibodies, MonoclonalAntilymphocyte Serum